PCM
PFE icon

Polymer Capital Management’s Pfizer PFE Stock Holding History

Polymer Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,695
Closed -$690K – 977
2025
Q4 		$690K Buy
27,695
+5,709
+26% +$144K 0.07% 393
2025
Q3 		$560K Buy
+21,986
New +$543K 0.06% 403
2025
Q2 		– Sell
-21,979
Closed -$557K – 732
2025
Q1 		$557K Buy
+21,979
New +$575K 0.14% 147

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Polymer Capital Management's PFE Position: Q1 2026 in Review

Polymer Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 27,695 shares — an estimated $690K sold.

Polymer Capital Management first reported a position in PFE in Q1 2025 and held it in 3 quarters. The position peaked at $690K in Q4 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Polymer Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Polymer Capital Management sold 27,695 Pfizer shares in Q1 2026, an estimated $690K.
  • Polymer Capital Management first reported a position in Pfizer in Q1 2025 and held it in 3 quarters.
  • Polymer Capital Management's Pfizer position peaked at $690K in Q4 2025.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.